samedan logo
 
 
spacer
home > epc > autumn 2006 > critical coverage
PUBLICATIONS
European Pharmaceutical Contractor

Critical Coverage

Recognising and responding to the common causes for the deterioration of stock contained in a controlled environment is vital in the long-term battle for cost and operational efficiency. Keith Gallois and Gerry Heffernan of Chubb Insurance report

Wouldn’t you rather be in control of the risks that face your business instead of hoping that your insurance policy will cover you in the event of a disaster? Property loss incidents within the biopharmaceutical sector are fairly infrequent, whereas losses arising from a change in controlled environment – mostly malfunction or loss of power to fridges or freezers – are comparatively high. The storage of refrigerated stock is a key exposure faced by most contract manufacture or research organisations, and the successful management of this exposure needs to form part of any integrated risk management programme.

ASSESSING THE RISK

To understand the risks you face, the first thing you need to do is carry out an initial assessment of the risk exposure. You need to evaluate how business-critical the contents of the refrigeration units are. Values may range from a few hundred pounds if contents are stored there merely to extend shelf life, to hundreds of thousands of pounds and months of valuable time to replace, impacting your revenue and your client’s research and development operations. An initial assessment should include the following questions:


Read full article >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Keith Gallois is a Senior Loss Control Representative at Chubb Insurance and an Associate of the Chartered Insurance Institute. Keith has over 16 years’ experience of managing risk for multinational clients, with the last five of these specifically targeted towards the biotech and medical device industry. As well as providing risk management advice to Chubb’s life science clients, Keith’s role also embraces active risk management relationships with this industry sector as a whole.

Gerry Heffernan leads Chubb’s Life Science Specialty Group in the UK and Ireland, and is a Senior Life Science Property Underwriting Specialist. Gerry has over 20 years’ commercial underwriting experience, and for the past seven years has focused on the biotech and medical device industry. Through client interaction he has helped to develop policy wordings that target the unique and varied exposures faced by biopharmaceutical customers.

spacer
Keith Gallois
spacer
spacer
spacer
Gerry Heffernan
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

4th Annual Patient Recruitment and Retention in Clinical Trials

13-15 October 2008, Amsterdam

Patient recruitment is now consuming thirty percent of clinical trial time - more time than any other clinical trial activity - and almost half of all trial delays result from patient recruitment problems. As the recruiting culture becomes more sophisticated and the forces affecting patient enrollment grow more numerous and complex, pharmaceutical companies are striving to discover new strategies to facilitate enrollment in clinical trials. With increasing industry pressure to develop, test and market greater numbers of new drugs faster, pharmaceutical companies need to perform clinical trials as quickly as possible. Inefficient patient recruitment processes is a formidable barrier to pharmaceutical companies' success in launching new products. Improving the patient recruitment process is imperative to avoid wasted investments and eliminate costly delays in bringing new drugs to market -- today and even more so in the not-so-distant future. Improved patient recruitment presents one of the largest opportunities for pharmaceutical companies to eliminate delays in clinical trials, thereby making it possible to reduce time to market.  With patent time limits and large overheads meaning that any delays in the development timeline can be disastrous, a good understanding of how to successfully recruit patients for trials is vital for any company looking to succeed.
More info >>

 
News and Press Releases

“PACK DIFFERENT” with EMBALLAGE 2008

“Business, Innovation, Outlook” are the watchwords for the 38th World Packaging Exhibition which opens in Paris from 17 to 21 November 2008. Fifteen months before the key packaging event of the end of 2008, EMBALLAGE displays its differences to offer you a new edition that is even more representative, international and rich in new features.
More info >>

 

©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement